Director's Dealing • Dec 18, 2019
Director's Dealing
Open in ViewerOpens in native device viewer
National Storage Mechanism | Additional information
RNS Number : 3476X
UDG Healthcare Public Limited Co.
18 December 2019
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
These forms are required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)
1
Details of the person discharging managerial responsibilities/person closely associated
a)
Name
Liam Logue
Reason for the notification
a)
Position/status
PDMR - Head of Corporate Development - UDG Healthcare plc
b)
Initial Notification Amendment
Initial Notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
UDG Healthcare plc
b)
LEI
549300IWG5ZPP6B8HH13
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument,
type of
instrument
Identification code
Ordinary Shares of €0.05 each in UDG Healthcare plc
ISIN: IE0033024807
b)
Nature of the transaction
(i) Exercise of share option award over 52,319 ordinary shares
(ii) Subsequent sale of 24,295 shares to cover tax. The balance of 28,024 shares was retained.
c)
Price(s) and volume(s)
| Price | Volume |
| (i) €0.05 per share | 52,319 Ordinary Shares (exercise) |
| (ii) £8.385 per share | 24,295 Ordinary Shares (sale) |
d)
Aggregated information
- Aggregated volume
- Price
N/A
e)
Date of the transaction
2019-12-16
f)
Place of the transaction
London Stock Exchange, Main Market
g)
Additional Information
For further information, please contact:
Damien Moynagh
General Counsel & Company Secretary
Tel: +353-1-4689000
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
END
DSHLLFVLFALTLIA
Building tools?
Free accounts include 100 API calls/year for testing.
Have a question? We'll get back to you promptly.